Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 17, 2008
Diabetes 57:1419-1426, 2008
DOI: 10.2337/db07-1466
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1466v1
57/5/1419    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Freathy, R. M.
Right arrow Articles by Frayling, T. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freathy, R. M.
Right arrow Articles by Frayling, T. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI

Rachel M. Freathy1, Nicholas J. Timpson2,3, Debbie A. Lawlor3,4, Anneli Pouta5, Yoav Ben-Shlomo4, Aimo Ruokonen5, Shah Ebrahim6, Beverley Shields1, Eleftheria Zeggini2, Michael N. Weedon1, Cecilia M. Lindgren2,7, Hana Lango1, David Melzer1, Luigi Ferrucci8, Giuseppe Paolisso9, Matthew J. Neville7, Fredrik Karpe7, Colin N.A. Palmer10, Andrew D. Morris10, Paul Elliott11, Marjo-Riitta Jarvelin5,11, George Davey Smith3,4, Mark I. McCarthy2,7, Andrew T. Hattersley1, and Timothy M. Frayling1

1 Peninsula Medical School, Exeter, U.K
2 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K
3 MRC Centre for Causal Analyses in Translational Epidemiology, Bristol University, Bristol, U.K
4 Department of Social Medicine, Bristol University, Bristol, U.K
5 National Public Health Institute and University of Oulu, Oulu, Finland
6 London School of Hygiene and Tropical Medicine, London, U.K
7 Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K
8 National Institute on Aging, National Institutes of Health, Bethesda, Maryland
9 II University of Naples, Naples, Italy
10 Ninewells Hospital and Medical School, University of Dundee, Nethergate, Dundee, Scotland, U.K
11 Department of Epidemiology and Public Health, Imperial College, London, U.K

Corresponding author: Prof. Timothy M. Frayling, Institute of Biomedical and Clinical Science, Peninsula Medical School, Magdalen Rd., Exeter, EX1 2LU, U.K. E-mail: tim.frayling{at}pms.ac.uk

Abbreviations: ALT, alanine aminotransferase; BWHHS, British Women's Heart and Health Study; EFSOCH, Exeter Family Study of Childhood Health; GGT, {gamma}-glutamyl-transferase; NCEP, National Cholesterol Education Program; NFBC1966, Northern Finland Birth Cohort of 1966; NIA, National Institute on Aging; SNP, single nucleotide polymorphism; UKT2D GCC, U.K. Type 2 Diabetes Genetics Consortium Collection

OBJECTIVE—Common variation in the FTO gene is associated with BMI and type 2 diabetes. Increased BMI is associated with diabetes risk factors, including raised insulin, glucose, and triglycerides. We aimed to test whether FTO genotype is associated with variation in these metabolic traits.

RESEARCH DESIGN AND METHODS—We tested the association between FTO genotype and 10 metabolic traits using data from 17,037 white European individuals. We compared the observed effect of FTO genotype on each trait to that expected given the FTO-BMI and BMI-trait associations.

RESULTS—Each copy of the FTO rs9939609 A allele was associated with higher fasting insulin (0.039 SD [95% CI 0.013–0.064]; P = 0.003), glucose (0.024 [0.001–0.048]; P = 0.044), and triglycerides (0.028 [0.003–0.052]; P = 0.025) and lower HDL cholesterol (0.032 [0.008–0.057]; P = 0.009). There was no evidence of these associations when adjusting for BMI. Associations with fasting alanine aminotransferase, {gamma}-glutamyl-transferase, LDL cholesterol, A1C, and systolic and diastolic blood pressure were in the expected direction but did not reach P < 0.05. For all metabolic traits, effect sizes were consistent with those expected for the per allele change in BMI. FTO genotype was associated with a higher odds of metabolic syndrome (odds ratio 1.17 [95% CI 1.10–1.25]; P = 3 x 10–6).

CONCLUSIONS—FTO genotype is associated with metabolic traits to an extent entirely consistent with its effect on BMI. Sample sizes of >12,000 individuals were needed to detect associations at P < 0.05. Our findings highlight the importance of using appropriately powered studies to assess the effects of a known diabetes or obesity variant on secondary traits correlated with these conditions.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. T. Tan, R. Dorajoo, M. Seielstad, X. L. Sim, R. T.-H. Ong, K. S. Chia, T. Y. Wong, S. M. Saw, S. K. Chew, T. Aung, et al.
FTO Variants Are Associated With Obesity in the Chinese and Malay Populations in Singapore
Diabetes, October 1, 2008; 57(10): 2851 - 2857.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y.-C. Chang, P.-H. Liu, W.-J. Lee, T.-J. Chang, Y.-D. Jiang, H.-Y. Li, S.-S. Kuo, K.-C. Lee, and L.-M. Chuang
Common Variation in the Fat Mass and Obesity-Associated (FTO) Gene Confers Risk of Obesity and Modulates BMI in the Chinese Population
Diabetes, August 1, 2008; 57(8): 2245 - 2252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.